The implications of immunogenicity for protein-based multiple sclerosis therapies

Bruce A. Cohen*, Joel Oger, Alison Gagnon, Gavin Giovannoni

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

46 Scopus citations

Fingerprint

Dive into the research topics of 'The implications of immunogenicity for protein-based multiple sclerosis therapies'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

INIS

Neuroscience